Alamar Biosciences, Inc. (California) (ALMR)
32.74
-1.50
(-4.38%)
USD |
NASDAQ |
Aug 24, 16:00
32.74
0.00 (0.00%)
After-Hours: 20:00
Alamar Biosciences Net Income (Quarterly) : -13.20M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.20M |
| March 31, 2026 | -21.32M |
| Date | Value |
|---|---|
| June 30, 2025 | -7.023M |
| March 31, 2025 | -7.659M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| 10X Genomics, Inc. | -17.93M |
| Personalis, Inc. | -31.68M |
| Twist Bioscience Corp. | -35.05M |
| Adaptive Biotechnologies Corp. | -39.94M |
| Champions Oncology, Inc. | -0.667M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 29.43M |
| Total Expenses (Quarterly) | 42.63M |
| EPS Diluted (Quarterly) | -0.1902 |
| Enterprise Value | 2.177B |
| Gross Profit Margin (Quarterly) | 60.21% |
| Profit Margin (Quarterly) | -44.85% |
| Earnings Yield | -2.17% |
| Normalized Earnings Yield | -1.860 |